Anticoagulation: An overview of pharmacological agents and therapeutic implications in rheumatology

Authors:

Mevludin Mekić, Edin Begić, Berina Hasanović, Ada Đozić, Buena Aziri

Summary

The use of anticoagulant therapy is a part of the daily work of clinicians and a reason for fear, primarily due to the risk of bleeding. The use of anticoagulant drugs in rheumatology remains a challenge. First, a large number of clinicians consider rheumatic conditions as a hypercoagulable state, which often leads to wrong decisions. Second, the use of drugs in the treatment of rheumatic diseases may be associated with an increased risk of venous thromboembolism (VTE ), and they can have effect on dose of anticoagulant agent. The aim of this paper is to present the properties of anticoagulant therapy through the prism of rheumatological pathology.

Sažetak

Primjena antikoagulantne terapije dio je svakodnevnog rada kliničara i postupak koji izaziva strah, prvenstveno zbog opasnosti od krvarenja. Primjena antikoagulantnih lijekova u reumatologiji i dalje je izazovan postupak. Kao prvo, velik broj kliničara smatra reumatska stanja hiperkoagulabilnim stanjima, što često dovodi do donošenja pogrešnih odluka. Kao drugo, primjena lijekova u liječenju reumatskih bolesti može biti povezana s povećanim rizikom od venske tromboembolije (VTE ) te lijekovi mogu utjecati na dozu antikoagulansa. Cilj je ovog rada prikazati svojstva antikoagulantne terapije kroz prizmu patologije reumatskih bolesti.

Vol.: Reumatizam 2021;68(2):69–85

Preuzmi PDF